JDDonline.com

Future Issue

JOURNAL OF DRUGS IN DERMATOLOGY*
March 2012, Volume 11, Issue 3
Various Topics Covered


ORIGINAL ARTICLES:

Comparative Trial of 5% Dexpanthenol in Water-in-Oil Formulation with 1% Hydrocortisone Ointment in the Treatment of Childhood Atopic Dermatitis: A Pilot Study

  • Montree Udompataikul

A Phase 2, Open-Label, Investigator-Initiated Study to Evaluate the Safety and Efficacy of Apremilast in Subjects with Recalcitrant Allergic Contact or Atopic Dermatitis

  • Eva M. Volf, Shiu-Chung Au MD, Nicole Dumont, Pamela Scheinman MD, and Alice B. Gottlieb MD, PhD

Combination of Essential Oil of Melaleuca alternifolia and Iodine in the Treatment of Molluscum Contagiosum in Children

  • Eric Markum, MD, PhD, and John Baillie, MD

Efficacy and Safety of Clindamycin-Tretinoin Gel versus Clindamycin or Tretinoin Alone in Acne Vulgaris: a Randomized, Double-Blind, Vehicle-Controlled Study

  • Emily Hotchkin, Michael T. Jarratt MD, Tom Brundage, Aaron Potts, Beth Zib

Optimizing Topical Combination Therapy for the Treatment of Acne Vulgaris

  • Joshua Zeichner, MD, FAAD

A Randomized, Double-blind, Placebo-controlled, Pilot Study To Assess the Efficacy and Safety of Clindamycin 1.2% And Tretinoin 0.025% Combination Gel For The Treatment of Acne Rosacea over 12 weeks

  • Anne Lynn S. Chang MD, Maria Alora-Palli, MD, Xinaida T. Lima MD MPH, Tiffany C. Chang, Carol Cheng BA, Connie M. Chung BA,Omar Amir MS,Alexa B. Kimball MD MPH.

Clinical Efficacy of the Long-pulsed 1,064 nm Nd:YAG Laser Using a 5 mm Spot Diameter to Treat Onychomycosis

  • Utako Kimura, Kaori Takeuchi, Ayako Kinoshita, Kenji Takamori, Masataro Hiruma, Yasushi Suga

Vitamins D Supplementation in the Treatment of Atopic Dermatitis: A Clinical Trial Study

  • Morteza Amestejani, M.D., Pirouz Piran, M.D., Bahareh Seyed Salehi , M.D., Seyed Kamran Kamrava, Tooraj Maleki M.D., Mehdi Karami M.D., Navab Shamspour, M.S., Babak Ghalehbaghi, Pashoutan Alinia, M.D., Ashkan Heshmatzade Behzadi ,M.D.

An update on the long-term safety experience of ustekinumab: Results from the psoriasis clinical development program with up to four years of follow-up

  • Kristian Reich, MD, Kim A. Papp, MD, Christopher E.M. Griffiths, MD, Philippe O. Szapary, MD, Newman Yeilding, MD, Yasmine Wasfi, MD, Elyssa Ott, MPH, Ming-Chun Hsu, PhD, Mark Lebwohl, MD, Kenneth B. Gordon, MD

Treatment of Scabies by Using 8 & 10% Topical Sulfur Ointment in Different Regimens of Application

  • Khalifa E. Sharquie MD; PhD, Jamal R. Al-Rawi MD; MSc; FIBMS, Adil A. Noaimi MD; DDV; FICMS, Haitham M. Al-Hassany MD

CASE REPORTS:

Lupus-like reaction to subcutaneous interferon alpha at injection sites

  • Hubert M. Chodkiewicz, BS, Philip R. Cohen, MD, Kevin B. Kim, MD, Doina Ivan, MD, and Jeffrey E. Gershenwald, MD

Case of Elephantiasis Nostras Verrucosa Treated by Acitretin

  • Polat Mualla, MD, Sereflican Betul, MD

Hypopigmented cutaneous sarcoidosis responsive to minocycline

  • Caroline E. Schmitt, M.D., Sabrina G. Fabi, M.D., Tarun Kukreja, M.D., James S. Feinberg, M.D., J.D., M.P.H.

Long-term Etanercept use for Severe Generalized Psoriasis in a HIV-infected individual: A Case Study

  • Eric S Lee, Misha M Heller, Faranak Kamangar, Kelly Park MD, John YM Koo MD

Adrenergic Urticaria and Rheumatoid Arthritis in a Patient with Melanoma: An Intricate Medical Management

  • Giovanni Luigi Capella MD

* SUBJECT TO CHANGE